clarithromycin modified release 500 mg

DRUG2 trials

Sponsors

Abbott

Conditions

BronchitisRespiratory Tract Infection

Unknown Phase

Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)

CompletedNCT01075204

AbbottRespiratory Tract Infection

Start: 2011-01-31End: 2012-01-31Updated: 2013-02-12

Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis

CompletedNCT01354938

AbbottBronchitis

Start: 2011-05-31End: 2012-01-31Updated: 2013-02-06